Paragon Care (ASX:PGC): Healthcare Distribution Platform and FY2026 Update

Sonal Goyal

15 September 2026 03:45 AM AEST

Paragon Care (ASX:PGC): Healthcare Distribution Platform and FY2026 Update

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Paragon Care (ASX:PGC) provides healthcare equipment, devices and consumables.
The company operates across multiple Asia-Pacific healthcare markets.
FY2026 results highlighted Revenue growth and operational changes.
The Business supplies products across areas including medical devices and pharmaceuticals.
Cash flow, customer relationships and operational execution remain key areas to monitor.

Paragon Care (ASX:PGC) is a healthcare distribution company supplying medical equipment, devices, consumables and related products across Asia-Pacific markets. The company operates a broad healthcare platform serving hospitals, healthcare providers and other customers through its distribution network.

Company Overview

Paragon Care provides equipment, devices and consumables to the healthcare market and also distributes pharmaceuticals and complementary medicines.

The company supplies more than 60,000 products from approximately 2,000 brands to customers across multiple markets.

Operations extend across 11 Asia-Pacific markets, including Australia, New Zealand, Japan, Korea, Singapore and Hong Kong.

The business operates across healthcare categories including orthopaedics, vision, dental, diagnostics, medical imaging, animal health, aesthetics and robotics.

The company’s official information highlights its role as a healthcare solutions provider supporting customers across the Asia-Pacific region.

FY2026 Performance

Paragon Care reported FY2026 revenue of A$3.7 billion, representing growth compared with the prior year.

Underlying EBITDA increased during the period, while underlying net profit after tax declined.

The company reported a statutory loss during FY2026, influenced by specific business matters.

Operational Development

The company operates through ANZ and Asia segments, with both contributing to its healthcare distribution platform.

Paragon Care continued focusing on healthcare product distribution, operational efficiency and expansion opportunities.

The company’s Asian operations contributed additional revenue through organic growth and acquisitions.

Risks and Considerations

Healthcare distribution businesses are exposed to customer concentration, pricing pressure and changes in healthcare demand.

Operations across multiple countries involve currency, regulatory and market-related considerations.

Debt levels, Working Capital Management and customer relationships remain important factors.

Key Insights

Paragon Care (ASX:PGC) operates a large healthcare distribution platform across Asia-Pacific markets. Future progress will depend on operational execution, customer relationships, expansion activities and management of financial resources.

FAQs

Q:What is the ASX ticker for Paragon Care?

A:Paragon Care trades under (ASX:PGC).

Q:What does Paragon Care do?

A:The company supplies healthcare equipment, devices, consumables and related products.

Q:Where does Paragon Care operate?

A:The company operates across Asia-Pacific markets.

Q:What products does Paragon Care distribute?

A:The company distributes healthcare products including medical devices, equipment and consumables.

Q:What factors are important for Paragon Care?

A:Operations, customer demand, expansion and financial management are key factors to monitor.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.